Telomerase activity and its clinicopathological significance in gastric cancer

European Journal of Cancer Part A

Volumn 33, Issue 8, 1997, Pages 1309-1313

  Ahn, M J ^d   Noh, Y H ^a   Lee, Y S ^b   Lee, J H ^b   Chung, T J ^d   Kim, I S ^d   Choi, I Y ^d   Kim, S H ^c   Lee, J S ^c   Lee, K H ^c  

^a Hanyang University College of Medicine   (South Korea)

^b Konkuk University   (South Korea)

^c University of Ulsan   (South Korea)

^d NONE

Author keywords

DNA flow cytometry; Gastric cancer; K RAS oncogene; Telomerase

Indexed keywords

DNA; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CARCINOGENESIS; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PLOIDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL RATE;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; GENES, RAS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PLOIDIES; POINT MUTATION; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; SURVIVAL RATE; TELOMERASE;

EID: 0008278075     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00113-5     Document Type: Article

References (33)

1. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993, 9, 138-141.
2. Wright PA, William GT. Molecular biology and gastric carcinoma. Gut 1993, 34, 145-147.
3. Shay JW, Wright WE, Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochem Biophys Acta 1991, 1072, 1-7.
4. Stamps AC, Gusterson BA, O'Hare MJ. Are tumor immortal? Eur J Cancer 1992, 28A, 1495-1500.
5. Harley CB, Futcher AB, Greider CW. Telomeres shortening during aging of human fibroblasts. Nature (London) 1990, 345, 458-460.
6. Lindsey J, McGill NI, Lindsey LA, Green DK, Kooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991, 256, 45-48.
7. Allsopp RC, Vaziri H, Petterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89, 10114-10118.
8. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43, 405-413.
9. Yu GL, Bradley JD, Attardi LD. In vivo alteration of telomerase sequence caused by mutated Tetrahymena telomerase RNAs. Nature (London) 1990, 344, 126-132.
10. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
11. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus transformed human B lymphocytes. J Virol 1994, 68, 3410-3414.
12. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo human malignant hematopoietic cells. Oncogene 1994, 9, 3043-3048.
13. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Nature (London) 1990, 346, 866-868.
14. Vaziri H. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993, 52, 661-667.
15. Vaziri H, Dragowski W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc natl Acad Sci USA 1994, 91, 9857-9860.
16. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, 11, 1921-1929.
17. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989, 59, 521-529.
18. Levy S, Urbano-Ispizua A, Gill R, et al. Multiple K-RAS codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991, 51, 3497-3502.
19. Lee KH, Lee JS, Suh C, et al. Clinicopathologic significance of the K-RAS codon 12 mutation in stomach cancer. Cancer 1995, 75, 2794-2801.
20. Sanger F, Nicklen S, Coulson R. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977, 74, 5367-5463.
21. Lee KH, Lee JS, Ahn MJ, et al. DNA flow cytometry of stomach cancer: prospective correlation with clinicopathologic findings. Cancer 1993, 72, 1819-1826.
22. Dressler LG, Bartow SA. DNA flow cytometry in solid tumors: practical aspects and clinical applications. Semin Diagn Pathol 1989, 6, 55-82.
23. Ahn MJ, Noh YH, Lee YS. Telomerase activity in head and neck cancer. Korean J Biochem 1995, 27, 219-223.
24. Noh YH, Ahn MJ, Lee YS, Cho SH, Kim KS, Hwang YY. Telomerase activity in human cervical tissues: comparison between invasive cervical carcinoma, carcinoma in situ, and dysplasia (abstract). Ann Congr Korean Cancer Assoc 1996, 22, 148.
25. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995, 55, 3258-3262.
26. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995, 55, 2533-2536.
27. Kokal WA, Gardine RL, Sheibani K, et al. Tumor DNA content in resectable, primary colorectal carcinoma. Ann Surg 1989, 209, 188-193.
28. Giaretti W, Danova M, Geido E, et al. Flow cytometric DNA index in the prognosis of colorectal cancer. Cancer 1991, 67, 1921-1927.
29. Volm M, Hahn EW, Mattern J, et al. Five-year follow up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res 1988, 48, 2923-2928.
30. Look AT, Douglass EC, Meyer WH. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. N Engl J Med 1988, 318, 1567-1572.
31. Noguchi Y, Ysuburaya A, Mikino T, et al. Predictive value of c-erb-2 and DNA ploidy pattern in gastric carcinoma recurrence. Int Surg 1993, 78, 107-111.
32. Nanus DM, Kelsen DP, Mentle IR, Altorki N, Albino AP. Infrequent point mutations of ras oncogene in gastric cancers. Gastroenterology 1990, 98, 955-960.
33. Miki H, Ohmori M, Perantoni AO, Enomoto T. K-ras activation in gastric epithelial tumors in Japanese. Cancer Lett 1991, 58, 107-113.